Stock Price
252.93
Daily Change
0.06 0.02%
Monthly
-4.03%
Yearly
6.89%
Q1 Forecast
245.23

ResMed reported $922.04M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Ansell USD 584.7M 126.8M Jun/2025
Artivion USD 90.55M 3.82M Sep/2025
AtriCure USD 78.49M 459K Dec/2025
Baxter International USD 2.23B 228M Dec/2025
Cochlear AUD 499.4M 107.8M Jun/2025
Cooper Companies USD 846M 35M Sep/2025
CSL USD 6.47B 327M Jun/2025
Dexcom USD 629.1M 25M Dec/2025
Edwards Lifesciences USD 1.14B 800K Sep/2025
Fisher Paykel Healthcare NZD 358.9M 67.1M Jun/2022
Globus Medical USD 759.28M 12.26M Dec/2025
Haemonetics USD 321.18M 15.02M Dec/2025
Hologic USD 688.5M 9.1M Dec/2025
Idexx Laboratories USD 377.76M 13.81M Dec/2025
Inogen USD 25.08M 762K Sep/2025
Insulet USD 452.6M 6.3M Dec/2025
Integra LifeSciences USD 492.73M 3.63M Dec/2025
Intuitive Surgical USD 1.84B 58.1M Dec/2025
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.16B 270M Sep/2025
Philips EUR 3.26B 28M Sep/2025
Ramsay Health Care AUD 404.4M 25M Jun/2025
ResMed USD 922.04M 23.76M Dec/2025
Sigma Healthcare AUD 324.85M 25.65M Jan/2023
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Steris USD 673.5M 15M Dec/2025
Teleflex USD 802.46M 108.78M Sep/2025
Thermo Fisher Scientific USD 5.43B 320M Dec/2025